Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy

Prognosis of patients with hepatocellular carcinoma (HCC) who undergo transcatheter intra-arterial therapies, including transcatheter arterial chemoembolization and transcatheter arterial infusion chemotherapy, is affected by many clinical factors including liver function and tumor progression. Howe...

Full description

Saved in:
Bibliographic Details
Published in:Cancer management and research 2018-01, Vol.10, p.2231-2239
Main Authors: Kobayashi, Takamasa, Kawai, Hirokazu, Nakano, Oki, Abe, Satoshi, Kamimura, Hiroteru, Sakamaki, Akira, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Yamagiwa, Satoshi, Terai, Shuji
Format: Article
Language:English
Subjects:
Adipose tissue
Albumin
Body composition
Body fat
Cancer
Cancer patients
Cancer therapies
Carcinoma
Care and treatment
CAT scans
Chemotherapy
Clinical outcomes
Diagnostic imaging
Glycoproteins
Health aspects
Hepatitis
Hepatocellular carcinoma
Hepatology
Liver
Liver cancer
Liver diseases
Lymphoma
Medical prognosis
Medical research
Medical schools
Metastasis
Multiple myeloma
Musculoskeletal system
Obesity
Original Research
Prognosis
Prostate cancer
Sarcopenia
Skeletal muscle
subcutaneous adipose tissue
Tomography
transcatheter arterial chemoembolization
transcatheter arterial infusion chemotherapy
Tumors
Value-added tax
Veins & arteries
Vertebrae
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prognosis of patients with hepatocellular carcinoma (HCC) who undergo transcatheter intra-arterial therapies, including transcatheter arterial chemoembolization and transcatheter arterial infusion chemotherapy, is affected by many clinical factors including liver function and tumor progression. However, the effect of body composition such as skeletal muscle and visceral and subcutaneous adipose tissues (VAT and SAT, respectively) on the prognosis of these patients remains unclear. We investigated the prognostic value of body composition in HCC patients treated with transcatheter intra-arterial therapies. This study retrospectively evaluated 100 HCC patients treated with transcatheter intra-arterial therapies between 2005 and 2015. Areas of skeletal muscle, VAT, and SAT were measured on computed tomography images at third lumbar vertebra level and normalized by the height squared to calculate the skeletal muscle index, VAT index, and SAT index (SATI). The visceral to subcutaneous adipose tissue area ratio was also calculated. Overall survival (OS) was compared between high- and low-index groups for each body composition. Furthermore, prognostic significance was assessed by univariate and multivariate analyses using Cox proportional hazards models. Among the body composition indexes, only SATI could significantly differentiate OS ( =0.012). Multivariate analysis showed that SATI (low- vs. high-SATI: HR, 2.065; 95% CI, 1.187-3.593; =0.010), serum albumin (
ISSN:1179-1322
1179-1322
DOI:10.2147/cmar.s167417